ベルギーの炎症性腸疾患患者のためのエビデンスベースの品質指標セットの開発
Liselotte Fierens1, Claire Liefferinckx2, João Sabino1,3
1Department of Chronic Diseases and Metabolism, KU Leuven, Leuven.
Journal of clinical gastroenterology
|February 20, 2026
まとめ
ベルギーの炎症性腸疾患 (IBD) の治療のために,199の品質指標の検証されたセットが開発されました. これには,改善のための18の主要指標,患者の福祉を優先し,臨床実務の強化が含まれています.
科学分野:
- 胃腸内科と肝臓病理学について
- 医療サービス 研究 医療サービス
- 品質改善 科学 科学 改善
背景:
- 標準化された品質指標は,炎症性腸疾患 (IBD) のケアを最適化するために不可欠です.
- 既存の品質指標セットは,ベルギーにおけるIBDの具体的な適用が欠如しています.
- ベルギーのIBDサービスに合わせた品質評価の枠組みが必要である.
研究 の 目的:
- ベルギーの臨床IBDケアのための包括的な品質指標のセットを開発し,検証する.
- ベルギーにおけるIBD管理の質の評価と改善のための枠組みを確立する.
- ベルギーのIBDセンターにおける品質改善イニシアチブの重要な分野を特定する.
主な方法:
- IBDの専門家32人が参加した変更されたDelphi演習は2ラウンドで行われました.
- 第3ラウンドでは,フォーカスグループからの患者の視点を取り入れ,患者の利益のための指標の優先順位付けに焦点を当てました.
- 合意またはコンセンサスが80%以上に達した指標は,最終的な検証セットに含まれていた.
主要な成果:
- 合計199の品質指標が検証されました: 41の構造指標,123のプロセス指標,35の成果指標です.
- 改善のための18の指標のサブセットが特定され,患者の特徴,内視鏡検査,感染制御,ステロイド使用,ケアチーム,クリニックサービス,ドキュメント,ケアパス,および疾患モニタリングをカバーしました.
- 患者は,疾患活動モニタリング,ケアパス,IBDケアチームに関連する指標の重要性を強調しました.
結論:
- ベルギーのIBDセンターには,優先順位付けの改善サブセットを含む,検証された品質指標のセットが確立されています.
- このセットは,現在のIBD治療の評価を可能にし,品質改善プロジェクトの開始を容易にする.
- 開発された指標は,ベルギーのIBDのケア基準をさらに向上させるためのベンチマークをサポートすることができます.
関連する概念動画
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
950
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
950
Inflammatory Bowel Disease IV: Pharmacological Management
832
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
832
Inflammatory Bowel Disease I: Ulcerative Colitis
1.2K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.2K
Inflammatory Bowel Disease II: Crohn's Disease
1.3K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.3K
Inflammatory Bowel Disease V: Surgical Management
747
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
747
Drugs for Treatment of Ulcerative Colitis in IBD
553
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
553


